{"id":5570,"date":"2019-11-19T06:27:52","date_gmt":"2019-11-19T06:27:52","guid":{"rendered":"https:\/\/jurmed.ro\/pacienti\/?p=5570"},"modified":"2019-11-19T06:27:52","modified_gmt":"2019-11-19T06:27:52","slug":"arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient","status":"publish","type":"post","link":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/","title":{"rendered":"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT"},"content":{"rendered":"<p style=\"text-align: justify\"><strong>Bucure\u0219ti, 13 noiembrie 2019 \u2013 <\/strong>\u00cen urma public\u0103rii raportului IQVIA \u201eEvaluarea inova\u021biilor terapeutice centrate pe pacient\u201d (\u201cAssessing Person-Centered Therapeutic Innovations\u201d), Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente (ARPIM) se al\u0103tur\u0103 eforturilor Federa\u021biei Europene a Industriilor \u0219i Asocia\u021biilor Farmaceutice (EFPIA &#8211; European Federation of Pharmaceutical Industries and Associations) \u0219i face un apel pentru includerea experien\u021bei \u0219i preferin\u021belor pacientului \u00een evaluarea Tehnologiilor Medicale (HTA &#8211;\u00a0 Health Technology Assessment), procesul care st\u0103 la baza deciziei de acces pentru noi medicamente \u0219i \u00een deciziile de stabilire a pre\u021burilor \u0219i de rambursare.<\/p>\n<p style=\"text-align: justify\">Inova\u021biile terapeutice centrate pe pacient pot avea un impact semnificativ \u0219i tangibil asupra calit\u0103\u021bii vie\u021bii pacientului, \u00eembun\u0103t\u0103\u021besc aderen\u021ba \u0219i, ca urmare, \u00eembun\u0103t\u0103\u021besc rezultatele. Pentru buget, acestea aduc economii datorit\u0103 unui rezultat clinic mai bun, a unei monitoriz\u0103ri simplificate \u0219i a competi\u021biei de pre\u021b.<br \/>\nCu toate acestea, raportul arat\u0103 c\u0103 multe organisme HTA \u0219i pl\u0103titori nu le iau \u00een considerare \u00eentr-un mod semnificativ \u00een evaluarea noilor tratamente.<\/p>\n<p style=\"text-align: justify\">Raportul IQVIA\u00a0 \u201eEvaluarea inova\u021biilor terapeutice centrate pe pacient\u201d (\u201cAssessing Person-Centered Therapeutic Innovations\u201d) a fost realizat prin analizarea medicamentelor noi lansate \u00eentre 2011 \u0219i 2018, \u00een 8 \u021b\u0103ri europene ( Fran\u021ba, Germania, Marea Britanie, Italia, Spania, Suedia, Olanda \u0219i Polonia), \u00een arii terapeutice precum HIV, diabet, neurologie, oncologie, scleroz\u0103 multipl\u0103, boli respiratorii. Peste 900 de rapoarte HTA au fost analizate \u0219i 27 de entit\u0103\u021bi din s\u0103n\u0103tate au fost intervievate (pl\u0103titori, reprezentan\u021bi ai pacien\u021bilor, clinicieni \u0219i academicieni).<\/p>\n<p style=\"text-align: justify\"><strong>Deficien\u021be privind accesul \u00een Rom\u00e2nia: 43 de luni pentru compensarea unui medicament<\/strong><\/p>\n<p style=\"text-align: justify\">\u201cAcest raport scoate \u00een eviden\u021b\u0103 modul \u00een care to\u021bi cei implica\u021bi \u00een deciziile privind s\u0103n\u0103tatea \u0219i accesul la medicamente ar trebui s\u0103 se raporteze la inova\u021biile \u00een domeniu. \u00cen acela\u0219i timp, raportul subliniaz\u0103 \u00eenc\u0103 o dat\u0103 decalajul dintre Rom\u00e2nia \u0219i alte \u021b\u0103ri europene \u00een aceast\u0103 privin\u021b\u0103. Rom\u00e2nia nu a fost inclus\u0103 \u00een acest studiu, sistemul HTA local fiind unul care depinde de evaluarea \u0219i accesul medicamentelor \u00een sistem de rambursare \u00een alte \u021b\u0103ri europene\u201d, a declarat Dan Zaharescu, Director Executiv ARPIM.<\/p>\n<p style=\"text-align: justify\">Rom\u00e2nia este pe ultimele locuri \u00een Europa \u00een ceea ce prive\u0219te accesul pacien\u021bilor la medicamente inovatoare \u0219i, de\u0219i s-au f\u0103cut pa\u0219i importan\u021bi \u00een actualizarea listei de medicamente compensate, suntem departe de standardele europene de tratament. Principalele motive sunt un sistem de compensare inconstant \u0219i impredictibil. Timpul mediu p\u00e2n\u0103 la accesul unui nou medicament pe pia\u021ba din Rom\u00e2nia \u00een sistem de compensare, de la aprobarea Agen\u021biei Europene a Medicamentului, este de aproximativ 43 de luni, conform datelor ARPIM,\u00a0 \u00een timp ce al\u021bi europeni au acces imediat sau \u00een c\u00e2teva luni.<\/p>\n<p style=\"text-align: justify\">Inova\u021biile terapeutice centrate pe pacient reprezint\u0103 aproximativ 40% dintre toate terapiile lansate \u00eentre 2011 \u0219i 2018. Dac\u0103 excludem extensiile de indica\u021bii, inova\u021biile terapeutice centrate pe persoan\u0103 constituie 65-70% din totalul noilor terapii lansate \u00eentr-un an.<\/p>\n<p style=\"text-align: justify\">Raportul IQVIA, comandat de EFPIA, a eviden\u021biat diferen\u021ba semnificativ\u0103 \u00eentre modul \u00een care pl\u0103titorii \u0219i utilizatorii finali (pacien\u021bii \u0219i medicii) percep valoarea inova\u021biilor terapeutice centrate pe pacient. Raportul a constatat c\u0103 mul\u021bi dintre pl\u0103titori \u0219i autorit\u0103\u021bi HTA trec cu vederea de multe ori valoarea ad\u0103ugat\u0103 a acestor inova\u021bii. De fapt, multe organisme HTA nu iau \u00een considerare beneficiile experien\u021bei pacientului la propriu, fiind \u00een favoarea unei abord\u0103ri unice cu focus asupra rezultatelor clinice.<\/p>\n<p style=\"text-align: justify\">Mai multe detalii: EFPIA White Paper <a href=\"https:\/\/www.efpia.eu\/media\/413282\/assessing-person-centered-therapeutic-innovations-wpa4_web.pdf\">https:\/\/www.efpia.eu\/media\/413282\/assessing-person-centered-therapeutic-innovations-wpa4_web.pdf<\/a><\/p>\n<p style=\"text-align: justify\">Despre Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente (ARPIM)<\/p>\n<p>Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente (ARPIM)-www.arpim.ro-este organiza\u021bia care sus\u021bine obiectivele comune ale celor mai importante 28 de companii farmaceutice interna\u021bionale produc\u0103toare de medicamente originale, prezente \u00een Rom\u00e2nia.<\/p>\n<p style=\"text-align: justify\">Membrii ARPIM investesc permanent \u00een cercetare \u0219i dezvoltare, cu scopul de a le oferi pacien\u021bilor medicamente originale \u0219i inovatoare, care salveaz\u0103 anual mii de vie\u021bi. Principalul obiectiv al Asocia\u021biei este cre\u0219terea accesului pacien\u021bilor la medicamente, ameliorarea calit\u0103\u021bii vie\u021bii pacien\u021bilor \u0219i implicit cre\u0219terea speran\u021bei de via\u021b\u0103 a rom\u00e2nilor.<\/p>\n<p style=\"text-align: justify\">ARPIM este afiliat\u0103 la Federa\u021bia European\u0103 a Industriei Farmaceutice (EFPIA)-www.efpia.com-organiza\u021bia european\u0103 care reune\u0219te cele mai importante companii farmaceutice interna\u021bionale, recunoscute datorit\u0103 rezultatelor la nivelul comunit\u0103\u021bii \u0219tiin\u021bifice interna\u021bionale.<\/p>\n<p style=\"text-align: justify\"><strong>Companiile farmaceutice membre ARPIM sunt<\/strong>: Abbvie, Amgen, Angelini, Astellas, AstraZeneca, Bayer, Berlin-Chemie Menarini, Boehringer Ingelheim, Boiron, Bristol Myers Squibb, Chiesi, Eli Lilly, Genesis, GlaxoSmithKline, Ipsen, Johnson &amp; Johnson, Lundbeck, Merck Romania, Merck Sharp &amp; Dohme, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Servier, Takeda, UCB, Vifor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bucure\u0219ti, 13 noiembrie 2019 \u2013 \u00cen urma public\u0103rii raportului IQVIA \u201eEvaluarea inova\u021biilor terapeutice centrate pe pacient\u201d (\u201cAssessing Person-Centered Therapeutic Innovations\u201d), Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente (ARPIM) se al\u0103tur\u0103 [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5570","post","type-post","status-publish","format-standard","category-stiri-noutati"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT<\/title>\n<meta name=\"description\" content=\"Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente ARPIM face APEL PT EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT\" \/>\n<meta property=\"og:description\" content=\"Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente ARPIM face APEL PT EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/\" \/>\n<meta property=\"og:site_name\" content=\"Jurmed - Pacienti\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-19T06:27:52+00:00\" \/>\n<meta name=\"author\" content=\"Alina\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/\"},\"author\":{\"name\":\"Alina\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582\"},\"headline\":\"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT\",\"datePublished\":\"2019-11-19T06:27:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/\"},\"wordCount\":793,\"commentCount\":0,\"articleSection\":[\"Stiri \/ Noutati\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/\",\"url\":\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/\",\"name\":\"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#website\"},\"datePublished\":\"2019-11-19T06:27:52+00:00\",\"author\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582\"},\"description\":\"Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente ARPIM face APEL PT EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT\",\"breadcrumb\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jurmed.ro\/pacienti\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#website\",\"url\":\"https:\/\/jurmed.ro\/pacienti\/\",\"name\":\"Jurmed - Pacienti\",\"description\":\"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jurmed.ro\/pacienti\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582\",\"name\":\"Alina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6d9f8e49326fb2e29a59f96348688ad5b800d4cee212a8329ed5c51ca5d31570?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6d9f8e49326fb2e29a59f96348688ad5b800d4cee212a8329ed5c51ca5d31570?s=96&r=g\",\"caption\":\"Alina\"},\"url\":\"https:\/\/jurmed.ro\/pacienti\/author\/alinad\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT","description":"Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente ARPIM face APEL PT EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/","og_locale":"ro_RO","og_type":"article","og_title":"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT","og_description":"Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente ARPIM face APEL PT EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT","og_url":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/","og_site_name":"Jurmed - Pacienti","article_published_time":"2019-11-19T06:27:52+00:00","author":"Alina","twitter_misc":{"Scris de":"Alina","Timp estimat pentru citire":"4 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/#article","isPartOf":{"@id":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/"},"author":{"name":"Alina","@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582"},"headline":"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT","datePublished":"2019-11-19T06:27:52+00:00","mainEntityOfPage":{"@id":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/"},"wordCount":793,"commentCount":0,"articleSection":["Stiri \/ Noutati"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/","url":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/","name":"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT","isPartOf":{"@id":"https:\/\/jurmed.ro\/pacienti\/#website"},"datePublished":"2019-11-19T06:27:52+00:00","author":{"@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582"},"description":"Asocia\u021bia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u021bionali de Medicamente ARPIM face APEL PT EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT","breadcrumb":{"@id":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/jurmed.ro\/pacienti\/arpim-apel-pentru-evaluarea-si-prioritizarea-inovatiilor-terapeutice-centrate-pe-pacient\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jurmed.ro\/pacienti\/"},{"@type":"ListItem","position":2,"name":"ARPIM: APEL PENTRU EVALUAREA \u0218I PRIORITIZAREA INOVA\u021aIILOR TERAPEUTICE CENTRATE PE PACIENT"}]},{"@type":"WebSite","@id":"https:\/\/jurmed.ro\/pacienti\/#website","url":"https:\/\/jurmed.ro\/pacienti\/","name":"Jurmed - Pacienti","description":"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jurmed.ro\/pacienti\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Person","@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582","name":"Alina","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6d9f8e49326fb2e29a59f96348688ad5b800d4cee212a8329ed5c51ca5d31570?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6d9f8e49326fb2e29a59f96348688ad5b800d4cee212a8329ed5c51ca5d31570?s=96&r=g","caption":"Alina"},"url":"https:\/\/jurmed.ro\/pacienti\/author\/alinad\/"}]}},"_links":{"self":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts\/5570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/comments?post=5570"}],"version-history":[{"count":2,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts\/5570\/revisions"}],"predecessor-version":[{"id":5572,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts\/5570\/revisions\/5572"}],"wp:attachment":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/media?parent=5570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/categories?post=5570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/tags?post=5570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}